Corticosteroid and Biologic Use Not Associated With Adverse Outcomes for Inflammatory Bowel Disease Patients Hospitalized With COVID-19

BACKGROUND: To date, studies investigating the inflammatory bowel disease (IBD) patient experience with coronavirus disease 2019 (COVID-19) have consistently reported that the observed rate of COVID-19 within this population is similar to the general population. Limited research has suggested that c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultan, Keith, Durbin, Laura, Bhardwaj, Richa, Mackey, James, Becher, Noah, Abureesh, Mohammad, Lakhani, Komal, Mone, Anjali, Abergel, Jeffrey, Trindade, Arvind, Korelitz, Burton I., Swaminath, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734496/
https://www.ncbi.nlm.nih.gov/pubmed/35059066
http://dx.doi.org/10.14740/gr1447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734496/
https://www.ncbi.nlm.nih.gov/pubmed/35059066
http://dx.doi.org/10.14740/gr1447

Ejemplares similares